🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
pMMR/MSS and 32 dMMR/MSI-H patientspatients were planned to be enrolled. Pa...
Status
Unknown
Location
Zhengjiang Cancer Hospital
Start Date
2022-11-01
Trial ID
NCT05669092
Treatments Being Tested
This research study is a Phase 2 clinical trial. It will test the efficienc...
Status
Unknown
Location
Qingdao central Hospital
Start Date
2022-01-01
Trial ID
NCT05218629
Treatments Being Tested
This randomized controlled trial aims to evaluate the efficacy and safety o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07524413
This is a phase II, non-randomized, open-label, single-center study to eval...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2021-05-01
Trial ID
NCT04542369
Treatments Being Tested
The PraG treatment model has synergistic effects with RANKL inhibitor thera...
Status
Unknown
Location
The Second Affiliated Hospital of Soochow University
Start Date
2022-08-16
Trial ID
NCT05435768
Treatments Being Tested
In patients with locally advanced head and neck squamous cell carcinoma und...
Status
Recruiting
Location
Sun yat-sen memorial hospital
Start Date
2023-01-01
Trial ID
NCT05980715
Treatments Being Tested
The purpose of this study is to assess the clinical activity and safety of ...
Status
Completed
Location
California Cancer Associates for Research and Excellence, Inc.
Start Date
2019-01-09
Trial ID
NCT03679767
Treatments Being Tested
To explore the efficacy and safety of fruquintinib and albumin-paclitaxel c...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2024-04-15
Trial ID
NCT06417892
Treatments Being Tested
Prospective, open-label, phase 1 study of CD40 agonist (LVGN7409) and PD-1 ...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2024-07-02
Trial ID
NCT06159621
Treatments Being Tested
SCR-ESCC-02 is a multicenter, phase I/II clinical study to investigate the ...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2023-01-10
Trial ID
NCT06173986
Treatments Being Tested